november AG

euro adhoc: november AG
other
IBL reaches agreement Subsidiary of november AG goes to Meddens Diagnostic BV

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Contracts

28.07.2008

IBL Gesellschaft für Immunchemie und Immunbiologie mbH, a 100% subsidiary of november AG, Erlangen, is sold to Meddens Diagnistics BV, Amsterdam in an asset deal transaction. IBL had filed for insolvency last year. The transaction is to be concluded in the next month.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: november AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN:      DE000A0S9N72
WKN:        A0S9N7
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade



Weitere Meldungen: november AG

Das könnte Sie auch interessieren: